Market Overview:
The global clozapine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of schizophrenia and other psychotic disorders, rising geriatric population, and growing demand for novel therapies. The tablet segment accounted for the majority share of the global clozapine market in 2018 and is expected to maintain its dominance during the forecast period. By application, hospital held the largest share of the global clozapine market in 2018.
Product Definition:
Clozapine is a medication used to treat schizophrenia. It can help reduce symptoms such as hallucinations and delusions.
Tablet:
Tablet is a form of oral solid dosage drug delivery which is administered to patients suffering from schizophrenia. The tablet consists of the active ingredient (usually a antipsychotic) and an inert filler such as lactose or mannitol. It’s mechanism of action differs from that of a capsule in that it delivers the drug in its molten state, which allows it to be absorbed more quickly than if it were dispersed in water or other liquid solutions.
Oral Suspension:
Oral suspension is a drug delivery form that consists of solid or liquid medication mixed with flavoring agents and/or sweeteners in an amount to make the formulation taste good. It can be administered directly to the patient by mouth (by oral route) or it can be put in food and beverages for patients who are unable to take medications by mouth.
Application Insights:
Based on application, the global clozapine market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in 2018 with a share of about 58%. This can be attributed to growing prevalence of schizophrenia and other psychotic disorders coupled with increasing awareness among patients regarding treatment. Furthermore, government initiatives such as National Health Insurance in China have played an important role in increasing access to mental health services for rural residents. These factors are expected to drive demand for clozapine over the forecast period.
Regional Analysis:
North America dominated the global market in 2018. The presence of key players, availability of branded generic drugs, and high treatment rate are some factors responsible for its largest share. Moreover, increasing awareness about mental disorders and strong support from government & healthcare organizations are expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast years due to rising disposable income and growing population especially in China & India which has a high prevalence rate for schizophrenia as compared to other countries in this region. In addition, increase in research funding by governments is contributing towards progress within this industry making Asia Pacific an attractive destination for Clozapine manufacturers at present time.
Growth Factors:
- Increasing prevalence of schizophrenia and other psychotic disorders: The global prevalence of schizophrenia is estimated to be around 21 million, and the incidence is about 3-5 per 1000 population. Clozapine is considered as a first line treatment for patients with refractory schizophrenia. Thus, the increasing prevalence of schizophrenia would drive the growth of clozapine market.
- Rising awareness about clozapine benefits: There is a growing awareness among healthcare professionals about the benefits of clozapine over other antipsychotic drugs in terms of efficacy and tolerability. This would help to drive the growth of clozapine market in future.
- Launch of novel long-acting formulations: In recent years, there has been an increase in numberof novel long-acting formulations launched for clozapine therapy such as FazaClo HD (clorazepate dipotassium) extended release tablets and CloZAPINE LA (clonazepam) extended release capsules . These new formulations would help to expand the user base for clozapine and boost its sales revenue in coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Clozapine Market Research Report
By Type
Tablet, Oral Suspension, By type?tablet is the most commonly used type, with over 90% market share in 2018.
By Application
Hospital, Clinic, Others, By application, hospital is the largest segment, with market share of about 58% in 2018.
By Companies
Mylan, HLS, Jazz Pharmaceuticals, Mayne Pharma Inc., Teva Pharmaceuticals, Aurobindo Pharma USA Inc., Sun Pharmaceutical Industries Inc., Jiangsu Nhwa Pharmaceutical, Qilu Pharmaceutical, Hunan Dongting Pharmaceutical, Shanghai Pharmaceuticals Sine, Dahongying, PIDI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Clozapine Market Report Segments:
The global Clozapine market is segmented on the basis of:
Types
Tablet, Oral Suspension, By type?tablet is the most commonly used type, with over 90% market share in 2018.
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others, By application, hospital is the largest segment, with market share of about 58% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- HLS
- Jazz Pharmaceuticals
- Mayne Pharma Inc.
- Teva Pharmaceuticals
- Aurobindo Pharma USA Inc.
- Sun Pharmaceutical Industries Inc.
- Jiangsu Nhwa Pharmaceutical
- Qilu Pharmaceutical
- Hunan Dongting Pharmaceutical
- Shanghai Pharmaceuticals Sine
- Dahongying
- PIDI
Highlights of The Clozapine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Oral Suspension
- By type?tablet is the most commonly used type, with over 90% market share in 2018.
- By Application:
- Hospital
- Clinic
- Others
- By application, hospital is the largest segment, with market share of about 58% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clozapine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clozapine is an antipsychotic medication used to treat schizophrenia and other mental disorders. It works by blocking the action of chemicals in the brain that can cause symptoms such as hallucinations, delusions, and thinking problems. Clozapine may also help improve moods and reduce anxiety.
Some of the major players in the clozapine market are Mylan, HLS, Jazz Pharmaceuticals, Mayne Pharma Inc., Teva Pharmaceuticals, Aurobindo Pharma USA Inc., Sun Pharmaceutical Industries Inc., Jiangsu Nhwa Pharmaceutical, Qilu Pharmaceutical, Hunan Dongting Pharmaceutical, Shanghai Pharmaceuticals Sine, Dahongying, PIDI.
The clozapine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clozapine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clozapine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clozapine Market - Supply Chain
4.5. Global Clozapine Market Forecast
4.5.1. Clozapine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clozapine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Clozapine Market Absolute $ Opportunity
5. Global Clozapine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Clozapine Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Oral Suspension
5.3.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Clozapine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Clozapine Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.3.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Clozapine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Clozapine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Clozapine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Clozapine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Clozapine Demand Share Forecast, 2019-2026
9. North America Clozapine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Clozapine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Clozapine Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.4.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Clozapine Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Oral Suspension
9.7.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Clozapine Demand Share Forecast, 2019-2026
10. Latin America Clozapine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Clozapine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Clozapine Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.4.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Clozapine Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Oral Suspension
10.7.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Clozapine Demand Share Forecast, 2019-2026
11. Europe Clozapine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Clozapine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Clozapine Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.4.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Clozapine Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Oral Suspension
11.7.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Clozapine Demand Share, 2019-2026
12. Asia Pacific Clozapine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Clozapine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Clozapine Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.4.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Clozapine Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Oral Suspension
12.7.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Clozapine Demand Share, 2019-2026
13. Middle East & Africa Clozapine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Clozapine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Clozapine Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.4.4. By application, hospital is the largest segment, with market share of about 58% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Clozapine Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Oral Suspension
13.7.3. By type?tablet is the most commonly used type, with over 90% market share in 2018.
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Clozapine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Clozapine Market: Market Share Analysis
14.2. Clozapine Distributors and Customers
14.3. Clozapine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mylan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. HLS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jazz Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mayne Pharma Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aurobindo Pharma USA Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceutical Industries Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Jiangsu Nhwa Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Qilu Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hunan Dongting Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shanghai Pharmaceuticals Sine
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Dahongying
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PIDI
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
